Literature DB >> 11737049

New approaches to inducing the death of alloreactive lymphocytes.

S M Krams1.   

Abstract

Mesh:

Substances:

Year:  2001        PMID: 11737049      PMCID: PMC1906240          DOI: 10.1046/j.1365-2249.2001.01737.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  20 in total

1.  Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance.

Authors:  Y Li; X C Li; X X Zheng; A D Wells; L A Turka; T B Strom
Journal:  Nat Med       Date:  1999-11       Impact factor: 53.440

2.  Down-regulation of human alloimmune responses by genetically engineered expression of CD95 ligand on stimulatory and target cells.

Authors:  H J Dulat; C von Grumbkow; W Baars; N Schröder; K Wonigeit; R Schwinzer
Journal:  Eur J Immunol       Date:  2001-07       Impact factor: 5.532

3.  Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice.

Authors:  H T Lau; M Yu; A Fontana; C J Stoeckert
Journal:  Science       Date:  1996-07-05       Impact factor: 47.728

4.  Fas ligand-induced apoptosis as a mechanism of immune privilege.

Authors:  T S Griffith; T Brunner; S M Fletcher; D R Green; T A Ferguson
Journal:  Science       Date:  1995-11-17       Impact factor: 47.728

5.  Soluble Fas ligand is chemotactic for human neutrophilic polymorphonuclear leukocytes.

Authors:  L Ottonello; G Tortolina; M Amelotti; F Dallegri
Journal:  J Immunol       Date:  1999-03-15       Impact factor: 5.422

6.  Il-12 antagonism enhances apoptotic death of T cells within hepatic allografts from Flt3 ligand-treated donors and promotes graft acceptance.

Authors:  W Li; L Lu; Z Wang; L Wang; J J Fung; A W Thomson; S Qian
Journal:  J Immunol       Date:  2001-05-01       Impact factor: 5.422

7.  A role for CD95 ligand in preventing graft rejection.

Authors:  D Bellgrau; D Gold; H Selawry; J Moore; A Franzusoff; R C Duke
Journal:  Nature       Date:  1995-10-19       Impact factor: 49.962

8.  Accelerating the induction of Fas-mediated T cell apoptosis: a strategy for transplant tolerance?

Authors:  H P Carroll; S Ali; J A Kirby
Journal:  Clin Exp Immunol       Date:  2001-12       Impact factor: 4.330

9.  The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis.

Authors:  N Itoh; S Yonehara; A Ishii; M Yonehara; S Mizushima; M Sameshima; A Hase; Y Seto; S Nagata
Journal:  Cell       Date:  1991-07-26       Impact factor: 41.582

10.  Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen.

Authors:  A Oehm; I Behrmann; W Falk; M Pawlita; G Maier; C Klas; M Li-Weber; S Richards; J Dhein; B C Trauth
Journal:  J Biol Chem       Date:  1992-05-25       Impact factor: 5.157

View more
  1 in total

1.  Dynamic Imaging of Marrow-Resident Granulocytes Interacting with Human Mesenchymal Stem Cells upon Systemic Lipopolysaccharide Challenge.

Authors:  Jay T Myers; Deborah S Barkauskas; Alex Y Huang
Journal:  Stem Cells Int       Date:  2013-03-27       Impact factor: 5.443

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.